Apr. 15 at 11:04 PM
$CDNA
Preliminary First Quarter 2026 Financial Results
Revenue of approximately
$118 million, growth of 39% year-over-year
Testing Service Volume of approximately 54,900, growth of 17% year–over-year
Testing Service revenue of approximately
$91 million, growth of 48% year–over-year,
Average revenue per test of approximately
$1,660 including approximately
$14 million in prior period revenue
Patient and Digital Solutions revenue of approximately
$16 million, growth of 33% year-over-year
Lab Products revenue of approximately
$10 million, decline of 4% year-over-year
Cash, cash equivalents, and marketable securities of approximately
$198 million as of March 31, 2026
